tirzepatide and uti Understanding GLP-1 Symptoms: Hyoscyamine Insights Nancy Rahnama, MD | What

Common positive reports include reduced joint stiffness and morning pain (likely primarily from weight loss), improved energy levels after initial adjustment, better mood and reduced brain fog, improved sleep quality, and feeling that their autoimmune medications "work better" than before starting tirzepatide

As always, check in with your provider if something feels off or persistent

Tirzepatide (Mounjaro, Zepbound) is an FDA-approved dual GIP/GLP-1 receptor agonist for type 2 diabetes and chronic weight management, while multiple sclerosis is a chronic autoimmune disorder affecting the central nervous system

Congressional action

While patients may hope to maintain their lowest achieved weight, research suggests that maintaining a portion of initial weight loss is a more achievable long-term outcome for many individuals